LOS ANGELES, May 6, 2011 /PRNewswire/ -- Last week in Alexandria, VA, the Department of Health and Human Services (HHS) Office of Grants and Acquisition Policy and Accountability (OGAPA) recognized the National Institutes of Health's Commercialization Assistance Program (and its Niche Assessment Program) for a special "team" recognition award for superior efforts to assist over 600 companies in bringing their applications to market and "contributing to public health." The award was made at the 2011 Acquisition, Grants, and Small Business Symposium. CEO Rohit Shukla was present and recognized as part of the team. The two-day symposium also highlighted various aspects of the acquisition, grants, and small business planning process to enrich stakeholder and customer knowledge.
The Larta-managed National Institutes of Health Commercialization Assistance Program (NIH-CAP) has assisted more than 600 NIH-funded SBIR Phase II businesses identify and accomplish their commercialization goals. The NIH-CAP is a 10-month mentoring and partnering-oriented effort geared to accelerate the commercial and market readiness of award-winning life science companies supported by NIH institutes across a variety of health care areas. Since 2004, Larta has assisted 105 NIH-CAP companies raise over $410 million in capital, and has had 12 acquisitions (10 companies and 2 technologies) result from the program. As part of this effort, Larta Institute has developed a compelling innovation "eco system" with industry, domain and functional experts focused on helping to advance these innovative products and services.
One of the many successful past participants in Larta's NIH-CAP is Colorado engineering company, Quest Product Development Corp. Quest participated in the 2008-09 NIH-CAP program cycle, working to continue research into their novel CardioQuest™ Cardiac Synchronization Technology.
CEO of Quest, James Houston, found great benefit from NIH-CAP participation, s
|SOURCE Larta Institute|
Copyright©2010 PR Newswire.
All rights reserved